Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling

JACC Heart Fail. 2015 Jan;3(1):68-69. doi: 10.1016/j.jchf.2014.10.003. Epub 2014 Nov 11.
No abstract available

Keywords: biomarkers; mineralicorticoid receptor antagonist; remodeling.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Animals
  • Galectin 3 / antagonists & inhibitors*
  • Galectin 3 / pharmacology*
  • Heart Failure / drug therapy*
  • Interleukins / genetics*
  • Male
  • Myocardial Infarction / drug therapy*
  • Receptors, Interleukin-1 / genetics*
  • Spironolactone / therapeutic use*
  • Up-Regulation / drug effects*
  • Ventricular Dysfunction, Left / drug therapy*
  • Ventricular Remodeling*

Substances

  • Galectin 3
  • Interleukins
  • Receptors, Interleukin-1
  • Spironolactone